Ana Maria Arance

基本信息

浏览量：129

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 289 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain

Natalia Castrejon,Roberto Martin, Antonio Carrasco,Paola Castillo,Adriana Garcia,Raquel Albero-Gonzalez,Mireia Garcia,Marta Marginet, Nuria Palau,Monica Hernandez,Carla Montironi,Guillem Clot,Ana Arance,Llucia Alos,Cristina Teixido

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2024）

引用0浏览0WOS引用

Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study

Laurent Mortier,Lisa Villabona,Ben Lawrence,Ana Arance,Marcus O. Butler, Marie Beylot-Barry,Philippe Saiag,Mahtab Samimi,Paolo A. Ascierto,Francesca Spada, Michel De Pontville,Michele Maio,Alfonso Berrocal,Enrique Espinosa,Jaume Capdevila,Max Levin, Debasmita Das,Clemens Krepler,Dmitri Grebennik,Vanna Chiarion-Sileni

AMERICAN JOURNAL OF CLINICAL DERMATOLOGYno. 6 (2024): 987-996

引用0浏览0WOS引用

Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: an Oncologist’s Perspective on Current Knowledge

Clara Martínez-Vila,Europa Azucena González-Navarro,Cristina Teixido,Roberto Martin,Francisco Aya,Manel Juan,Ana Arance

International journal of molecular sciencesno. 17 (2024)

引用0浏览0WOS引用

Combination of Encorafenib and Binimetinib Followed by Ipilimumab and Nivolumab Versus Ipilimumab and Nivolumab in Patients with Advanced BRAF-V600E/K-mutated Melanoma: the Primary Analysis of an EORTC Randomized Phase II Study (EBIN)

Caroline Robert,Caroline Dutriaux,Felix Boakye Oppong,Michal Kicinski,Emilie Routier,Eve-Marie Neidhardt,Xavier Durando,Barouyr Baroudjian,Philippe Saiag,Caroline Gaudy-Marqueste,Paolo Antonio Ascierto,Ana Maria Arance,Michelangelo Russillo, Jean-Luc Perrot, Anne-sophie Govaerts,Emanuel Buhrer,Bastian Schilling,Mario Mandala,Paul Lorigan,Alexander Christopher Jonathan van Akkooi

JOURNAL OF CLINICAL ONCOLOGYno. 17_SUPPL (2024): LBA9503-LBA9503

引用0浏览0引用

Anti-PD-1 Alone or in Combination with Anti-Ctla-4 for Advanced Melanoma Patients with Liver Metastases

Ines Pires da Silva,Isabel Li,Selma Ugurel,Patricio Serra-Bellver, Avanti Andhale, Hannah Burnette,Francisco Aya,Jordan W. Conway,Jorja Braden,Matteo S. Carlino,Alexander M. Menzies,Michael Weichenthal,Peter Mohr,Ralf Gutzmer,Ana M. Arance,Douglas B. Johnson,Paul Lorigan,Dirk Schadendorf,Serigne N. Lo,Georgina V. Long

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy

Sarah A. Weiss,Mario Sznol,Montaser Shaheen,Miguel-Angel Berciano-Guerrero,Eva Munoz Couselo,Delvys Rodriguez-Abreu,Valentina Boni,Lynn M. Schuchter,Maria Gonzalez-Cao,Ana Arance, Wei,Apar Kishor Ganti,Ralph J. Hauke,Alfonso Berrocal,Nicholas O. Iannotti, Frank J. Hsu,Harriet M. Kluger

CLINICAL CANCER RESEARCHno. 1 (2024): 74-81

引用5浏览0WOS引用

Nature and Management of Melanoma Recurrences Following Adjuvant Anti-PD-1 Based Therapy

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

ADU-1604, a Novel CTLA-4 Blocking Antibody, to Modulate Pharmacodynamic Markers in Patients with PD1 Relapse/refractory Melanoma

Guillermo De Velasco, Piotr Rutkowski, Anna Maria Di Giacomo,Ana Maria Arance,Caroline Robert, Vanna Chiarion-Sileni,Ivan Marquez-Rodas, Jessica Kundapur,Julien Villaudy,Hans van Eenennaam, Laura Lassouw-Polman,Alexander M. Eggermont

Journal of Clinical Oncologyno. 16_suppl (2024): 9552-9552

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Clinical Professor

论文共 289 篇作者统计合作学者相似作者